Medical Manufacturing Technologies (MMT), a portfolio company of Arcline Investment Management and a global provider of medical device manufacturing solutions, has expanded its catheter manufacturing and automation technologies with the acquisition of R&D Engineering (R&D) from Biomerics. 

This acquisition strengthens MMT’s offerings in core technology areas and enhances its end-to-end services platform.

MMT has acquired all of R&D’s manufacturing operations, including its Cath-Tech product lines and reflow, laminating, hot boxes, and skiving machinery.

Robbie Atkinson, CEO of MMT, said: “The R&D acquisition strengthens our position as a leader in the catheter manufacturing solutions industry, expands our capabilities, and enables us to provide a more dynamic and comprehensive product offering for our customers. We are excited to welcome the R&D Engineering team into the MMT family.”

As a leading provider of manufacturing solutions for complex medical devices, MMT offers its customers a broad portfolio of technologies spanning catheter manufacturing, and centreless and electrochemical grinding, supporting innovation in medical devices used in interventional procedures in areas such as neurovascular and cardiovascular.

David Erickson, president of R&D, said: “We are excited for what lies ahead for R&D as an MMT company. The MMT team shares our focus on innovation, as well as our aim to expand our solution and service offerings. The acquisition represents a true win-win for our teams and customers.”

R&D intends to maintain its Brooklyn Park, MN operations where it will continue to provide precision catheter manufacturing equipment, machined components, tooling, and custom automation for the medical device markets. 

Cowen, Inc. served as financial advisor to MMT in connection with the transaction.